Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ALUR · OTC · United States · Surgical & Medical Instruments & Apparatus
In shortALLURION TECHNOLOGIES, INC. is loss-making, burns cash and holds more cash than debt, with revenue shrinking (−52.6% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -198.0% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -188.8% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | – | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.33× | 0/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -76.26 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -190.1% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 4 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 4 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 3 | 0/100 |
| Revenue growth volatility | 18.2% | 44/100 |
| Operating margin volatility | 62.7% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -38.1% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
The last 4 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | 64 | 53 | 32 | 15 |
| Cost of revenue | 13 | 12 | 11 | 5.7 |
| Gross profit | 51 | 41 | 22 | 9.6 |
| Research & development | 17 | 28 | 17 | 7.6 |
| Operating income | (32) | (79) | (50) | (30) |
| Interest expense | 4.4 | 11 | 2.3 | 0 |
| Pre-tax income | (38) | (83) | (6.5) | (29) |
| Income tax | 0.1 | 0.3 | 0.7 | 0.1 |
| Net income | (38) | (83) | (7.2) | (29) |
| Diluted EPS | −$37.75 | −$59.38 | −$3.20 | −$3.81 |
| Diluted shares (millions) | 1.1 | 1.4 | 2.2 | 7.5 |
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of ALLURION TECHNOLOGIES, INC. are included in the Investor plan. Try free for 7 days →
−76.26 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
1/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Mar 31, 2026 · Data updated May 15, 2026